Incyte
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 3,820 $14.86 $56,769
Sale
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 179,644 $14.86 $2,669,689
Sale
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 5,722 $14.86 $85,035
Sale
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 227,071 $14.71 $3,340,669
Sale
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 4,829 $14.71 $71,044
Sale
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 88,670 $14.71 $1,304,513
Sale
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 7,180 $14.71 $105,632
Sale
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 7,233 $14.71 $106,412
Sale
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 19,433 $14.94 $290,387
Sale
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 19,291 $14.94 $288,265
Sale
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 238,230 $14.94 $3,559,871
Sale
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 12,974 $14.94 $193,870
Sale
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 610,072 $14.94 $9,116,306
Sale
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 2,812 $14 $39,365
Sale
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 1,877 $14 $26,276
Sale
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 88,250 $14 $1,235,412
Sale
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 34,462 $14 $482,434
Sale
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 2,789 $14 $39,043
Sale
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 9,916 $14.08 $139,657
Sale
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 122,467 $14.08 $1,724,825
Sale
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 9,991 $14.08 $140,713
Sale
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 6,670 $14.08 $93,940
Sale
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 313,622 $14.08 $4,417,052
Sale
CHARDONNET LAURENT other: Vice President and Treas..
 Common Stock 15,618 $14.07 $219,667
Option
SCHRECK PATRICIA A officer: EVP, General Counsel
 Common Stock 94,960 $6.15 $584,004
Sale
SCHRECK PATRICIA A officer: EVP, General Counsel
 Common Stock 94,960 $13.86 $1,316,146
Option
SCHRECK PATRICIA A officer: EVP, General Counsel
 Non-Qualified Stock Options 94,960 $6.15 $584,004
Option
FRIEDMAN PAUL A director
 Incentive Stock Option (right to buy) 14,247 $5.46 $77,789
Option
FRIEDMAN PAUL A director
 Common Stock 25,142 $6.28 $157,766
Purchase
FRIEDMAN PAUL A director
 Common Stock 10,000 $10.43 $104,250
Purchase
HASTINGS DAVID C officer: Chief Financial Officer
 Common Stock 2,000 $10.24 $20,480
Option
SWAIN PAULA J officer: EVP, Human Resources
 Common Stock 97,917 $6.12 $599,252
Option
SWAIN PAULA J officer: EVP, Human Resources
 Non Qualified Stock Options 25,000 $6.27 $156,750
Sale
SWAIN PAULA J officer: EVP, Human Resources
 Common Stock 97,917 $13.15 $1,287,609
Option
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Incentive Stock Options 20,000 $4.19 $83,800
Sale
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Common Stock 20,000 $4.19 $83,800
Option
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Common Stock 20,000 $4.19 $83,800
Sale
FRIEDMAN STEVEN M. officer: EVP, Biology & Preclin..
 Common Stock 22,000 $10.9 $239,800
Purchase
FRIEDMAN PAUL A director
 Common Stock 9,400 $2.1 $19,740
Purchase
FRIEDMAN PAUL A director
 Common Stock 10,600 $2.1 $22,260
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 1,248 $2.16 $2,693
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
 3.5% Senior Convertible Note due 2011 2,000 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 11,232 $2.16 $24,239
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 312 $2.16 $673
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 3.5 % Senior Convertible Note due 2011 485,000 N/A N/A
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 3.5% Subordinated Convertible Note due 2011 97,000 N/A N/A
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 3.5 % Subordinated Convertible Note due 2011 388,000 N/A N/A
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 5 $2.16 $11
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 3.5% Senior Convertible Note due 2011 4,367,000 N/A N/A
Purchase
FRIEDMAN PAUL A director
 Common Stock 8,840 $2.2 $19,448

Showing 1100 to 1150 of 1431 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: